Literature DB >> 19109784

Statistical methods in cancer epidemiological studies.

Xiaonan Xue1, Donald R Hoover.   

Abstract

In this chapter, we discuss statistical methods for various study designs that are commonly used in epidemiological research and particularly in cancer epidemiological research. After a brief review of basic concepts in epidemiological studies, statistical methods for case-control studies and cohort studies are discussed. Statistical methods for nested case-control and case-cohort studies, which have been increasingly used in cancer epidemiology, also are discussed. This chapter is designed for cancer epidemiologists who understand basic statistical methods for commonly used epidemiological study designs and are able to initiate power and sample size calculations. Therefore, this chapter emphasizes newly developed statistical methods for epidemiological studies as well as study planning.

Entities:  

Mesh:

Year:  2009        PMID: 19109784     DOI: 10.1007/978-1-59745-416-2_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Associations of ABCB1 3435C>T and IL-10-1082G>A polymorphisms with long-term sirolimus dose requirements in renal transplant patients.

Authors:  Wai-Johnn Sam; Christine E Chamberlain; Su-Jun Lee; Joyce A Goldstein; Douglas A Hale; Roslyn B Mannon; Allan D Kirk; Yuen Yi Hon
Journal:  Transplantation       Date:  2011-12-27       Impact factor: 4.939

2.  Testing the proportional hazards assumption in case-cohort analysis.

Authors:  Xiaonan Xue; Xianhong Xie; Marc Gunter; Thomas E Rohan; Sylvia Wassertheil-Smoller; Gloria Y F Ho; Dominic Cirillo; Herbert Yu; Howard D Strickler
Journal:  BMC Med Res Methodol       Date:  2013-07-09       Impact factor: 4.615

3.  Use of general practice, diagnostic investigations and hospital services before and after cancer diagnosis - a population-based nationwide registry study of 127,000 incident adult cancer patients.

Authors:  Karina Garnier Christensen; Morten Fenger-Grøn; Kaare Rud Flarup; Peter Vedsted
Journal:  BMC Health Serv Res       Date:  2012-07-28       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.